CUC Future Growth
Future criteria checks 3/6
CUC is forecast to grow earnings and revenue by 15.5% and 18.5% per annum respectively. EPS is expected to grow by 13.3% per annum. Return on equity is forecast to be 12.7% in 3 years.
Key information
15.5%
Earnings growth rate
13.3%
EPS growth rate
Healthcare earnings growth | 9.2% |
Revenue growth rate | 18.5% |
Future return on equity | 12.7% |
Analyst coverage | Low |
Last updated | 13 Jun 2024 |
Recent future growth updates
Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
3/31/2027 | 60,505 | 3,975 | N/A | N/A | 1 |
3/31/2026 | 49,039 | 3,557 | -1,429 | 6,242 | 3 |
3/31/2025 | 42,950 | 2,425 | -1,026 | 4,768 | 2 |
3/31/2024 | 33,025 | 2,595 | -747 | 4,156 | N/A |
12/31/2023 | 31,133 | 1,779 | N/A | N/A | N/A |
9/30/2023 | 31,862 | 1,952 | N/A | N/A | N/A |
6/30/2023 | 32,737 | 1,992 | N/A | N/A | N/A |
3/31/2023 | 35,210 | 2,423 | N/A | N/A | N/A |
3/31/2022 | 35,314 | 2,707 | N/A | N/A | N/A |
3/31/2021 | 16,606 | 1,100 | N/A | N/A | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: 9158's forecast earnings growth (15.5% per year) is above the savings rate (0.2%).
Earnings vs Market: 9158's earnings (15.5% per year) are forecast to grow faster than the JP market (8.9% per year).
High Growth Earnings: 9158's earnings are forecast to grow, but not significantly.
Revenue vs Market: 9158's revenue (18.5% per year) is forecast to grow faster than the JP market (4.2% per year).
High Growth Revenue: 9158's revenue (18.5% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: 9158's Return on Equity is forecast to be low in 3 years time (12.7%).